Summary
Background
The impact of tumor location on prognosis is still controversial in patients with esophageal squamous cell carcinoma (ESCC). The purpose of this study was to investigate the impact of tumor location on prognosis in patients with thoracic ESCC and evaluate the scientific value of adding tumor location as a staging factor in the seventh edition of American Joint Cancer Committee staging system of ESCC.
Methods
We retrospectively analyzed the clinical data of 1,512 consecutive patients with thoracic ESCC who underwent esophagectomy in The First Affiliated Hospital of Zhengzhou University and The Cancer Center of Sun Yat-sen University from December 1996 to December 2008.
Results
Prognosis could be evaluated satisfactorily for the entire cohort of patients regardless of employing the sixth or the seventh edition staging system. In the entire cohort of patients, no significant difference in survival was found concerning different tumor locations (p > 0.05). In the patients staged T2-3N0M0, there was no significant difference in survival between upper/middle thoracic and lower thoracic groups (p > 0.05).
Conclusions
Adding tumor location as a staging factor in the new American Joint Cancer Committee staging system of ESCC may be not suitable for patients with ESCC in China.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Reference
Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116:3763–73.
Zhang HL, Liu RL, Shi YT, et al. Analysis of the survival in patients after surgical resection of thoracic esophageal cancer. Zhonghua Zhong Liu Za Zhi. 2009;31:541–5 (Chinese).
Ruol A, Castoro C, Portale G, et al. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009;144:247–54.
Yuequan J, Shifeng C, Bing Z. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery. Ann Thorac Surg. 2010;90:908–13.
Xie YT, Wang SQ, Huang JQ, et al. Analysis of prognostic factors in patients with thoracic esophageal squamous carcinoma after radical resection. Zhonghua Wei Chang Wai Ke Za Zhi. 2004;7:453–5 (Chinese).
Li H, Zhang Q, Xu L, et al. Factors predictive of prognosis after esophagectomy for squamous cell cancer. J Thorac Cardiovasc Surg. 2009;137:55–9.
Gertler R, Stein HJ, Langer R, et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee Staging System. Ann Surg. 2011;253:689–98.
Hsu PK, Wu YC, Chou TY, et al. Comparison of the 6th and 7th editions of the American Joint Committee on cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg. 2010;89:1024–31.
Conflict of interest
The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Wei Hu and Yayong Liang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Hu, W., Liang, Y., Zhang, S. et al. Impact of tumor location on prognosis in patients with thoracic esophageal squamous cell carcinoma. Eur Surg 45, 200–204 (2013). https://doi.org/10.1007/s10353-013-0223-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10353-013-0223-y